Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Ann Rheum Dis. 2022 Jan 13;81(6):798–804. doi: 10.1136/annrheumdis-2021-221915

Figure 1.

Figure 1.

Forest plot of propensity score fine stratification weighted hazard ratios and corresponding 95% confidence intervals for composite cardiovascular outcomes when comparing tofacitinib with tumor necrosis factor inhibitors in patients with rheumatoid arthritis in RWE cohort (top panel) and RCT-duplicate cohort (bottom panel)